Publications by authors named "Radim Vicik"

Claim this Profile
N
Nonpeptidic vinyl and allyl phosphonates as falcipain-2 inhibitors.
Roberta Ettari, Emanuela Nizi, Maria Emilia Di Francesco, Nicola Micale, Silvana Grasso

ChemMedChem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of peptidomimetics with a vinyl sulfone warhead as irreversible falcipain-2 inhibitors.
Roberta Ettari, Emanuela Nizi, Maria Emilia Di Francesco, Marie-Adrienne Dude, Gabriele Pradel

J Med Chem· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening of protease inhibitors as antiplasmodial agents. Part I: Aziridines and epoxides.
Franziska Schulz, Christoph Gelhaus, Björn Degel, Radim Vicik, Saskia Heppner

ChemMedChem· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aziridide-based inhibitors of cathepsin L: synthesis, inhibition activity, and docking studies.
Radim Vicik, Matthias Busemann, Christoph Gelhaus, Nikolaus Stiefl, Josef Scheiber

ChemMedChem· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational design of aziridine-containing cysteine protease inhibitors with improved potency: studies on inhibition mechanism.
Radim Vicik, Holger Helten, Tanja Schirmeister, Bernd Engels

ChemMedChem· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitors of cysteine proteases.
Radim Vicik, Matthias Busemann, Knut Baumann, Tanja Schirmeister

Curr Top Med Chem· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aziridine-2,3-dicarboxylates, peptidomimetic cysteine protease inhibitors with antileishmanial activity.
Alicia Ponte-Sucre, Radim Vicik, Martina Schultheis, Tanja Schirmeister, Heidrun Moll

Antimicrob Agents Chemother· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aziridine-2,3-dicarboxylate inhibitors targeting the major cysteine protease of Trypanosoma brucei as lead trypanocidal agents.
Radim Vicik, Verena Hoerr, Melanie Glaser, Martina Schultheis, Elizabeth Hansell

Bioorg Med Chem Lett· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening of electrophilic compounds yields an aziridinyl peptide as new active-site directed SARS-CoV main protease inhibitor.
Erika Martina, Nikolaus Stiefl, Björn Degel, Franziska Schulz, Alexander Breuning, Radim Vicik

Bioorg Med Chem Lett· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new lead for nonpeptidic active-site-directed inhibitors of the severe acute respiratory syndrome coronavirus main protease discovered by a combination of screening and docking methods.
Ulrich Kaeppler, Nikolaus Stiefl, Markus Schiller, Radim Vicik, Alexander Breuning

J Med Chem· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking effect of a biotinylated protease inhibitor on the egress of Plasmodium falciparum merozoites from infected red blood cells.
Christoph Gelhaus, Radim Vicik, Tanja Schirmeister, Matthias Leippe

Biol Chem· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and antiplasmodial activity of a cysteine protease-inhibiting biotinylated aziridine-2,3-dicarboxylate.
Christoph Gelhaus, Radim Vicik, Rolf Hilgenfeld, Christian L Schmidt, Matthias Leippe

Biol Chem· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis